Mark B. Leick

4.1k citations
56 papers · 3.0k · 6 hit papers · h-index 21

Impact in

  • Oncology top 1%
    • CAR-T cell therapy research
  • Immunology top 5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses

Papers in

    • CAR-T cell therapy research 41
    • Hematopoietic Stem Cell Transplantation 4

Mark B. Leick

52 papers receiving 3.0k citations

Mark B. Leick's Hit Papers

Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma 2024 · 85 citations
850+2+4Years since publication100200300400

Peers

Mark B. Leick
Comparison fields: 5 of 75
  • Oncology 2.3k
  • Immunology 729
  • Genetics 279
  • Hematology 210
  • Genetics 486
Replace Biagio De Angelis with:
Biagio De Angelis Italy
Sneha Ramakrishna United States
Rebecca C. Larson United States
Liora Michal Schultz United States
Oumar Diouf United States
Selene Nuñez-Cruz United States
Daniel B. Landi United States
Maksim Mamonkin United States
Jufen Chu United States
Lucila Nassif Kerbauy Brazil
Mark B. Leick relative to Biagio De Angelis Italy Biagio De Angelis's profile →
Citations per field
00.5×1.5×1.8×
Biagio De Angelis · 1×
Citations per year

Countries citing papers authored by Mark B. Leick

Since Specialization
Citations

This map shows the geographic impact of Mark B. Leick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Leick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Leick more than expected).

Fields of papers citing papers by Mark B. Leick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Leick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Leick. The network helps show where Mark B. Leick may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark B. Leick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark B. Leick Line = papers co-authored together Mark B. Leick links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1
CAR-T cells secreting BiTEs circumvent antigen escape without detectable toxicity
Hit paper breakdown →
2019481
2
Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma
Hit paper breakdown →
2024301
3
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
Hit paper breakdown →
2022280
4 2019250
5
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Hit paper breakdown →
2023243
6
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
Hit paper breakdown →
2022207
7 2019205
8 2022116
9 2022112
10 2022110
11 202193
12
Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma
Hit paper breakdown →
202485
13 202257
14 202353
15
Loss of imprinting of IGF2 and the epigenetic progenitor model of cancer.
201239
16 201736
17 202030
18 202326
19 202023
20 202423

About Mark B. Leick

Mark B. Leick is a scholar working on Oncology, Hematology, Immunology, Biomedical Engineering and Molecular Biology, having authored 56 papers that have together received 3.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (41 papers), Immune Cell Function and Interaction (11 papers), Nanowire Synthesis and Applications (10 papers), CRISPR and Genetic Engineering (6 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers), Integrated Circuits and Semiconductor Failure Analysis (5 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Oncology (2.3k citations), Immunology (729 citations), Genetics (279 citations), Hematology (210 citations) and Genetics (486 citations). Mark B. Leick has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Marcela Valderrama Maus, Matthew J. Frigault, Bryan D. Choi, Amanda A. Bouffard, William T. Curry, Bob S. Carter, Rebecca C. Larson, Stefanie R. Bailey, Kathleen Gallagher and Irene Scarfò. Their work appears in journals such as Blood, Journal for ImmunoTherapy of Cancer, Blood Advances, New England Journal of Medicine and Nature.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact